01521.HK
Frontage Holdings Corporation
HKSE · Healthcare · Biotechnology · US
HKD 1.03
−2.83%Margins
Gross margin
25.8%
EBITDA margin
19.3%
EBIT margin
7.9%
Net margin
3.8%
FCF margin
13.2%
3.0%
Return on equity
1.8%
Return on assets
4.4%
Return on invested capital
0.50x
Asset turnover
HKD 398.7M
Cash from operations
HKD 0.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026